spacer
The Healthcare Sales & Marketing Network celebrates 27 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  blood substitute 

 HSMN NewsFeed - 19 Apr 2011
Sangart Announces Closing of $50 Million Series G Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 6 May 2010
ThermoGenesis Names Leading Healthcare Industry Executive David Carter to Board of Directors
Devices Surgery Regenerative Medicine Personnel
 HSMN NewsFeed - 24 Mar 2009
Oxygen Biotherapeutics, Inc. Establishes Warfighter Division
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Oct 2008
Biopure Sues National Institutes of Health Official
Biopharmaceuticals
 HSMN NewsFeed - 19 May 2008
Sangart, Inc. Completes Enrollment in Second Phase III Study of Hemospan, a Novel Oxygen Transport Agent
Biopharmaceuticals
 HSMN NewsFeed - 8 May 2008
U.S. Navy Receives Funding for Further Development of Hemopure(R)
Biopharmaceuticals
 HSMN NewsFeed - 22 Apr 2008
Synthetic Blood International, Inc. to Seek Shareholder Approval for Name Change
Biopharmaceuticals
 HSMN NewsFeed - 4 Apr 2008
Synthetic Blood International, Inc. Announces Plans to File Protocol for Phase II-b Oxycyte(R) Clinical Trial
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 31 Mar 2008
Synthetic Blood International, Inc. Announces New Leadership Roles to Continue Product Development Strategy
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Mar 2008
Synthetic Blood International, Inc. Announces Passing of Interim CEO Robert Larsen
Biopharmaceuticals Personnel
 HSMN NewsFeed - 6 Mar 2008
Office of Naval Research Provides $3.5 Million in New Grants for Clinical Research Involving Synthetic Blood International's Oxycyte(R)
Biopharmaceuticals
 HSMN NewsFeed - 26 Feb 2008
Synthetic Blood Announces Department of Defense Grant for Traumatic Brain Injury Clinical Trial with Oxycyte
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 8 Feb 2008
Synthetic Blood Announces Medical Advisory Board Meeting Results, New Additions to Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Jan 2008
Sanguine Corporation Opens Satellite Office in West Chester Pennsylvania
Biopharmaceuticals
 HSMN NewsFeed - 17 Dec 2007
Synthetic Blood Announces Oxycyte Development Strategy
Biopharmaceuticals Neurology
 HSMN NewsFeed - 13 Dec 2007
Independent Data Safety Monitoring Board Recommends Continuation of Sangart's Pivotal Phase III Trials of Hemospan(R)
Biopharmaceuticals
 HSMN NewsFeed - 11 Dec 2007
Synthetic Blood Announces Progress with Oxycyte Program in Traumatic Brain Injury
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 28 Nov 2007
Synthetic Blood Announces VCURES Receives $1.3 Million From U.S. Navy for Decompression Sickness Research with Oxycyte
Biopharmaceuticals
 HSMN NewsFeed - 20 Nov 2007
Synthetic Blood Announces Major Restructuring
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Nov 2007
Biopure Submits Complete Response to U.K. Regulatory Body on Marketing Application for Hemopure(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 15 Oct 2007
Biopure Announces Expanded Clinical Program To Target Anemia
Biopharmaceuticals
 HSMN NewsFeed - 10 Oct 2007
Multicenter PolyHeme Trauma Study Presented at the American College of Surgeons 93rd Annual Clinical Congress
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2007
Positive Statistical Analysis from Synthetic Blood's Oxycyte Traumatic Brain Injury Trial Indicates Achievement of Primary Endpoint
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 May 2007
Sanguine Continues Work Toward FDA 510(k) Application
Devices FDA
 HSMN NewsFeed - 23 Jan 2007
Sanguine Receives FDA Meeting Minutes to Define PHER-O2 Regulatory Path
Biopharmaceuticals FDA
 HSMN NewsFeed - 10 Jan 2007
Biopure Provides Further Comment on U.K. Regulatory Body Letter Regarding Marketing Application for Hemopure(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 10 Jan 2007
Biopure Receives Comment Letter From U.K. Regulatory Body on Marketing Application for Hemopure(R)
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 22 Dec 2006
Synthetic Blood Reports Positive Preliminary Results From Traumatic Brain Injury Clinical Trial
Biopharmaceuticals Neurosurgery
 HSMN NewsFeed - 20 Dec 2006
Biopure Announces Next Steps for Navy's Proposed 'Resus' Trauma Trial of Hemopure(R)
Biopharmaceuticals
 HSMN NewsFeed - 7 Nov 2006
Biopure's Phase II Trauma Trial of Hemopure(R) in South Africa Continues Following Independent Panel's First Scheduled Interim Review
Biopharmaceuticals
 HSMN NewsFeed - 12 Jul 2006
Biopure Comments on Wall Street Journal Articles
Biopharmaceuticals
 HSMN NewsFeed - 12 Jul 2006
Synthetic Blood Updates Traumatic Brain Injury Trial Enrollment
Biopharmaceuticals
 HSMN NewsFeed - 11 Jul 2006
Biopure Applies for Marketing Authorization of Hemopure(R) In the United Kingdom
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 19 May 2006
Synthetic Blood Reaches First Half of Traumatic Brain Injury Trial
Biopharmaceuticals
 HSMN NewsFeed - 15 May 2006
Biopure Appoints Vice President of Medical Affairs
Biopharmaceuticals Personnel
Return to NewsFeed  

 Additional items found! 46

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 46 additional stories matching:
blood substitute
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.